RESEARCH-USE BIOSIMILAR ANTIBODY
Cetuximab
Monoclonal antibody · IgG1
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity.
TARGETEGFR
YMonoclonal antibody
CATALOGSC-BS-676
CATALOG NUMBERSC-BS-676
MOLECULAR WEIGHTApprox. 145.54 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity.
Cetuximab is a recombinant research-use antibody directed against EGFR.